Three Months Ended June 30,
|
||||||||||||||||
GAAP
|
Non-GAAP(1)
|
|||||||||||||||
2021
|
2020
|
2021
|
2020
|
|||||||||||||
(dollars in thousands, except per share data)
|
||||||||||||||||
Revenue
|
$
|
53,864
|
$
|
39,049
|
$
|
53,864
|
$
|
39,049
|
||||||||
Gross margin
|
40.2
|
%
|
49.6
|
%
|
40.5
|
%
|
49.7
|
%
|
||||||||
Income from operations
|
$
|
4,331
|
$
|
7,336
|
$
|
5,666
|
$
|
8,191
|
||||||||
Net income (loss) attributable to ACM Research, Inc.
|
$
|
6,567
|
$
|
(81
|
)
|
$
|
4,119
|
$
|
6,205
|
|||||||
Basic EPS
|
$
|
0.34
|
$
|
(0.00
|
)
|
$
|
0.22
|
$
|
0.34
|
|||||||
Diluted EPS
|
$
|
0.30
|
$
|
(0.00
|
)
|
$
|
0.19
|
$
|
0.29
|
Six Months Ended June 30,
|
||||||||||||||||
GAAP
|
Non-GAAP(1)
|
|||||||||||||||
2021
|
2020
|
2021
|
2020
|
|||||||||||||
(dollars in thousands, except per share data)
|
||||||||||||||||
Revenue
|
$
|
97,596
|
$
|
63,397
|
$
|
97,596
|
$
|
63,397
|
||||||||
Gross margin
|
40.7
|
%
|
46.7
|
%
|
40.9
|
%
|
46.8
|
%
|
||||||||
Income from operations
|
$
|
7,781
|
$
|
8,554
|
$
|
10,326
|
$
|
10,098
|
||||||||
Net income attributable to ACM Research, Inc.
|
$
|
12,037
|
$
|
1,624
|
$
|
11,846
|
$
|
8,599
|
||||||||
Basic EPS
|
$
|
0.63
|
$
|
0.09
|
$
|
0.62
|
$
|
0.48
|
||||||||
Diluted EPS
|
$
|
0.56
|
$
|
0.08
|
$
|
0.55
|
$
|
0.41
|
(1) |
Reconciliations to U.S. generally accepted accounting principles (“GAAP”) financial measures from non-GAAP financial measures are presented below under “Reconciliation of GAAP
to Non-GAAP Financial Measures.” Non-GAAP financial measures exclude stock-based compensation with respect to net income (loss) attributable to ACM Research, Inc. and basic and diluted EPS, and also exclude non-cash changes in fair value of
financial assets and liabilities and unrealized gain on trading securities.
|
• |
Shipments. Total shipments in the second quarter of 2021 were $82 million,
versus $45 million in the second quarter of 2020 and $74 million in the first quarter of 2021. Total shipments include deliveries for revenue in the quarter and deliveries of first tool systems awaiting customer acceptance for potential
revenue in future quarters.
|
• |
ECP Ramp. ACM continued to gain solid traction with its ECP product line in
the marketplace. ACM’s ECP ramp is progressing, with three ECP ap first tools delivered during the second quarter of 2021 and multiple ECP map and ECP ap tools scheduled for delivery in the second half of 2021.
|
• |
Production Capacity. ACM Shanghai increased the total available floor space at
its newly-leased second Chuansha factory building to 200,000 square feet, and expects to begin its initial production ramp at that facility in the third quarter of 2021.
|
• |
Bevel Etch Product. The new Bevel Etch product further expands ACM’s
comprehensive offering of wet tools. The new product uses a wet etch method to remove various types of dielectric, metal and organic material films, as well as particle contaminants on the wafer edge. We expect to deliver a first-tool Bevel
Etch product to a China-based logic customer in the third quarter of 2021.
|
• |
ACM Shanghai IPO. On June 10, 2021, the Shanghai Stock Exchange Commission
submitted ACM Shanghai’s application for registration for its STAR Market IPO to the China Securities Regulatory Commission. The timing and successful completion of the STAR Market IPO and listing are subject to the acceptance of the
registration application by the China Securities Regulatory Commission, and remains uncertain as it depends upon numerous factors beyond ACM Shanghai’s control.
|
• |
Revenue was $53.9 million, up 37.9%, reflecting an increase in revenue from wet
cleaning and other front-end processing tools, and advanced packaging, other advanced processing tools, services and spares.
|
• |
Gross margin was 40.2%, down from 49.6%. Non-GAAP gross margin, which excludes
stock-based compensation, was 40.5%, down from 49.7%. Gross margin was within the range of 40.0% to 45.0% set forth in the Company’s long-term business model. The Company expects gross margin to vary from period to period due to a variety of
factors, such as sales volume and product mix.
|
• |
Operating expenses were $17.3 million, an increase of 44.3%. Non-GAAP
operating expenses, which exclude stock-based compensation, were $16.1 million, up 43.9%. Non-GAAP operating expenses as a percent of revenue increased to 29.9% from 28.7%. Higher research and development spending on new products, expenses
related to sales activities, and legal expenses for preparation of ACM Shanghai’s STAR Market IPO and ACM’s civil suit defense contributed to the increase from the prior-year period.
|
• |
Operating income of $4.3 million reflected a decrease of 41.0%. Non-GAAP
operating income, which excludes stock-based compensation, was $5.7 million, down 30.8%.
|
• |
Unrealized gain on trading securities was $3.8 million in the second quarter of
2021. The gain reflects the change in market value of ACM Shanghai’s indirect investment in STAR Market IPO shares of Semiconductor Manufacturing
International Corporation (SMIC), which began trading in mid-July 2020. The value was marked-to-market at quarter-end and is excluded from non-GAAP results.
|
• |
Net income attributable to ACM Research, Inc. was $6.6 million, compared to a
net loss of $0.1 million. Non-GAAP net income attributable to ACM Research, Inc., which excludes stock-based compensation, unrealized gain on trading securities, and change in fair value of financial liability, was $4.1 million as compared
to $6.2 million. Tax-related items (compared to a normalized tax rate) and the effects of foreign-exchange fluctuations on operating results provided a net headwind of $0.3 million, compared to $0.9 million.
|
• |
Net income per diluted share attributable to ACM Research, Inc. was $0.30, compared to $0.00. Non-GAAP net income per diluted share, which excludes stock-based compensation, unrealized gain on trading securities, and
change in fair value of financial liability, was $0.19, compared to $0.29. Tax-related items and the effects of foreign-exchange fluctuations on operating results resulted in a net headwind of $0.01 per share, compared to a net headwind of
$0.04 per share.
|
• |
Cash and equivalents at quarter-end were $70.2 million, versus $78.8 million at the end of the first quarter of 2021 and $71.8 million at the end of 2020. The quarter-over-quarter decrease was primarily due to cash
flow used by operating activities.
|
Phone Number
|
Toll-Free Number
|
|
United States
|
+1 (661) 567-1217
|
+1 (833) 562-0137
|
Hong Kong
|
+852 5819 4851
|
+852 8009 66253
|
Mainland China
|
+86 8008700169
|
|
+86 4006828609
|
In the United States:
|
The Blueshirt Group
|
Ralph Fong
|
|
+1 (415) 489-2195
|
|
ralph@blueshirtgroup.com
|
|
In China:
|
The Blueshirt Group Asia
|
Gary Dvorchak, CFA
|
|
+86 (138) 1079-1480
|
|
gary@blueshirtgroup.com
|
June 30, 2021
|
December 31, 2020
|
|||||||
(Unaudited)
|
||||||||
(In thousands, except share and per share data)
|
||||||||
Assets
|
||||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$
|
70,209
|
$
|
71,766
|
||||
Trading securities
|
31,257
|
28,239
|
||||||
Accounts receivable, less allowance for doubtful accounts of $0 as of June 30, 2021 and December 31,
2020
|
71,357
|
56,441
|
||||||
Other receivables
|
10,733
|
9,679
|
||||||
Inventories
|
136,852
|
88,639
|
||||||
Prepaid expenses
|
8,953
|
5,892
|
||||||
Total current assets
|
329,361
|
260,656
|
||||||
Property, plant and equipment, net
|
8,985
|
8,192
|
||||||
Land use right, net
|
9,642
|
9,646
|
||||||
Operating lease right-of-use assets, net
|
5,209
|
4,297
|
||||||
Intangible assets, net
|
630
|
554
|
||||||
Deferred tax assets
|
14,691
|
11,076
|
||||||
Long-term investments
|
7,006
|
6,340
|
||||||
Other long-term assets
|
43,434
|
40,496
|
||||||
Total assets
|
418,958
|
341,257
|
||||||
Liabilities and Stockholders’ Equity
|
||||||||
Current liabilities:
|
||||||||
Short-term borrowings
|
22,162
|
26,147
|
||||||
Current portion of long-term borrowings
|
1,799
|
1,591
|
||||||
Accounts payable
|
67,031
|
35,603
|
||||||
Advances from customers
|
43,845
|
17,888
|
||||||
Deferred revenue
|
2,348
|
1,343
|
||||||
Income taxes payable
|
482
|
31
|
||||||
FIN-48 payable
|
83
|
83
|
||||||
Other payables and accrued expenses
|
21,871
|
18,805
|
||||||
Current portion of operating lease liability
|
2,437
|
1,417
|
||||||
Total current liabilities
|
162,058
|
102,908
|
||||||
Long-term borrowings
|
18,717
|
17,979
|
||||||
Long-term operating lease liability
|
2,772
|
2,880
|
||||||
Deferred tax liability
|
1,298
|
1,286
|
||||||
Other long-term liabilities
|
4,557
|
8,034
|
||||||
Total liabilities
|
189,402
|
133,087
|
||||||
Commitments and contingencies
|
||||||||
Stockholders’ equity:
|
||||||||
Common stock – Class A, par value $0.0001: 50,000,000 shares authorized as of June 30, 2021 and
December 31, 2020; 17,668,409 shares issued and outstanding as of June 30, 2021 and 16,896,693 shares issued and outstanding as of December 31, 2020
|
2
|
2
|
||||||
Common stock–Class B, par value $0.0001: 2,409,738 shares authorized as of June 30, 2021 and
December 31, 2020; 1,707,605 shares issued and outstanding as of June 30, 2021 and 1,802,606 shares issued and outstanding as of December 31, 2020
|
-
|
-
|
||||||
Additional paid in capital
|
108,566
|
102,004
|
||||||
Accumulated surplus
|
46,324
|
34,287
|
||||||
Accumulated other comprehensive income
|
5,931
|
4,857
|
||||||
Total ACM Research, Inc. stockholders’ equity
|
160,823
|
141,150
|
||||||
Non-controlling interests
|
68,733
|
67,020
|
||||||
Total stockholders’ equity
|
229,556
|
208,170
|
||||||
Total liabilities and stockholders’ equity
|
$
|
418,958
|
$
|
341,257
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
|||||||||||||||
2021
|
2020
|
2021
|
2020
|
|||||||||||||
(Unaudited)
|
(Unaudited)
|
|||||||||||||||
( In thousands, except share and per share data)
|
( In thousands, except share and per share data)
|
|||||||||||||||
Revenue
|
$
|
53,864
|
$
|
39,049
|
$
|
97,596
|
$
|
63,397
|
||||||||
Cost of revenue
|
32,184
|
19,693
|
57,871
|
33,813
|
||||||||||||
Gross profit
|
21,680
|
19,356
|
39,725
|
29,584
|
||||||||||||
Operating expenses:
|
||||||||||||||||
Sales and marketing
|
5,789
|
4,595
|
11,097
|
7,600
|
||||||||||||
Research and development
|
7,933
|
5,221
|
13,437
|
8,898
|
||||||||||||
General and administrative
|
3,627
|
2,204
|
7,410
|
4,532
|
||||||||||||
Total operating expenses, net
|
17,349
|
12,020
|
31,944
|
21,030
|
||||||||||||
Income from operations
|
4,331
|
7,336
|
7,781
|
8,554
|
||||||||||||
Interest income
|
31
|
320
|
80
|
655
|
||||||||||||
Interest expense
|
(194
|
)
|
(228
|
)
|
(383
|
)
|
(339
|
)
|
||||||||
Change in fair value of financial liability
|
-
|
(5,431
|
)
|
-
|
(5,431
|
)
|
||||||||||
Unrealized gain on trading securities
|
3,783
|
-
|
2,736
|
-
|
||||||||||||
Other income, net
|
(897
|
)
|
149
|
(428
|
)
|
826
|
||||||||||
Equity income in net income of affiliates
|
295
|
209
|
615
|
357
|
||||||||||||
Income before income taxes
|
7,349
|
2,355
|
10,401
|
4,622
|
||||||||||||
Income tax benefit (expense)
|
(15
|
)
|
(1,859
|
)
|
2,755
|
(2,163
|
)
|
|||||||||
Net income
|
7,334
|
496
|
13,156
|
2,459
|
||||||||||||
Less: Net income attributable to non-controlling interests and redeemable non-controlling interests
|
767
|
577
|
1,119
|
835
|
||||||||||||
Net income attributable to ACM Research, Inc.
|
$
|
6,567
|
$
|
(81
|
)
|
$
|
12,037
|
$
|
1,624
|
|||||||
Comprehensive income:
|
||||||||||||||||
Net income
|
7,334
|
496
|
13,156
|
2,459
|
||||||||||||
Foreign currency translation adjustment
|
3,000
|
242
|
1,668
|
(1,658
|
)
|
|||||||||||
Comprehensive Income
|
10,334
|
738
|
14,824
|
801
|
||||||||||||
Less: Comprehensive income attributable to non-controlling interests and redeemable non-controlling interests
|
1,797
|
1,610
|
1,714
|
916
|
||||||||||||
Comprehensive income attributable to ACM Research, Inc.
|
$
|
8,537
|
$
|
(872
|
)
|
$
|
13,110
|
$
|
(115
|
)
|
||||||
Net income attributable to ACM Research, Inc. per common share:
|
||||||||||||||||
Basic
|
$
|
0.34
|
$
|
(0.00
|
)
|
$
|
0.63
|
$
|
0.09
|
|||||||
Diluted
|
$
|
0.30
|
$
|
(0.00
|
)
|
$
|
0.56
|
$
|
0.08
|
|||||||
Weighted average common shares outstanding used in computing per share amounts:
|
||||||||||||||||
Basic
|
19,123,659
|
18,050,841
|
18,956,195
|
18,085,602
|
||||||||||||
Diluted
|
21,807,744
|
21,516,175
|
21,679,528
|
21,197,203
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
|||||||||||||||
Total Revenue By Product Category
|
2021
|
2020
|
2021
|
2020
|
||||||||||||
Single Wafer Cleaning Tools (SAPS, TEBO, Tahoe) and Semi-Critical Cleaning Equipment
|
$
|
45,461
|
$
|
33,340
|
$
|
77,874
|
$
|
56,124
|
||||||||
ECP (front-end and packaging), Furnace and Other Technologies
|
-
|
4,490
|
5,550
|
4,490
|
||||||||||||
Advanced Packaging (excluding ECP), and Services & Spare Parts
|
8,403
|
1,219
|
14,172
|
2,783
|
||||||||||||
$
|
53,864
|
$
|
39,049
|
$
|
97,596
|
$
|
63,397
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
|||||||||||||||
Total Revenue By Equipment Type (Front-end / Back-end)
|
2021
|
2020
|
2021
|
2020
|
||||||||||||
Wet cleaning and other front-end processing tools
|
$
|
45,974
|
$
|
37,830
|
$
|
77,874
|
$
|
60,614
|
||||||||
Advanced packaging, other processing tools, services & spares
|
7,890
|
1,219
|
19,722
|
2,783
|
||||||||||||
$
|
53,864
|
$
|
39,049
|
$
|
97,596
|
$
|
63,397
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
|||||||||||||||
Total Revenue By Region
|
2021
|
2020
|
2021
|
2020
|
||||||||||||
Mainland China
|
$
|
53,736
|
$
|
39,004
|
$
|
97,432
|
$
|
63,293
|
||||||||
Other Regions
|
128
|
45
|
164
|
104
|
||||||||||||
$
|
53,864
|
$
|
39,049
|
$
|
97,596
|
$
|
63,397
|
Three Months Ended June 30,
|
||||||||||||||||||||||||||||||||
2021
|
2020
|
|||||||||||||||||||||||||||||||
Actual
(GAAP)
|
SBC
|
Other non-operating adjustments
|
Adjusted
(Non-GAAP)
|
Actual
(GAAP)
|
SBC
|
Other non-operating adjustments
|
Adjusted
(Non-GAAP)
|
|||||||||||||||||||||||||
($ in thousands)
|
||||||||||||||||||||||||||||||||
Revenue
|
$
|
53,864
|
$
|
-
|
$
|
-
|
$
|
53,864
|
$
|
39,049
|
$
|
-
|
$
|
-
|
$
|
39,049
|
||||||||||||||||
Cost of revenue
|
(32,184
|
)
|
(110
|
)
|
-
|
(32,074
|
)
|
(19,693
|
)
|
(43
|
)
|
-
|
(19,650
|
)
|
||||||||||||||||||
Gross profit
|
21,680
|
(110
|
)
|
-
|
21,790
|
19,356
|
(43
|
)
|
-
|
19,399
|
||||||||||||||||||||||
Gross margin %
|
40.2
|
%
|
0.2
|
%
|
40.5
|
%
|
49.6
|
%
|
0.1
|
%
|
49.7
|
%
|
||||||||||||||||||||
Operating expenses:
|
||||||||||||||||||||||||||||||||
Sales and marketing
|
(5,789
|
)
|
(478
|
)
|
-
|
(5,311
|
)
|
(4,595
|
)
|
(164
|
)
|
-
|
(4,431
|
)
|
||||||||||||||||||
Research and development
|
(7,933
|
)
|
(279
|
)
|
-
|
(7,654
|
)
|
(5,221
|
)
|
(188
|
)
|
-
|
(5,033
|
)
|
||||||||||||||||||
General and administrative
|
(3,627
|
)
|
(468
|
)
|
-
|
(3,159
|
)
|
(2,204
|
)
|
(460
|
)
|
-
|
(1,744
|
)
|
||||||||||||||||||
Income from operations
|
$
|
4,331
|
$
|
(1,335
|
)
|
$
|
-
|
$
|
5,666
|
$
|
7,336
|
$
|
(855
|
)
|
$
|
-
|
$
|
8,191
|
||||||||||||||
Operating margin %
|
8.0
|
%
|
2.5
|
%
|
-
|
10.5
|
%
|
18.8
|
%
|
2.2
|
%
|
-
|
21.0
|
%
|
||||||||||||||||||
Change in fair value of financial liability
|
-
|
-
|
-
|
-
|
(5,431
|
)
|
-
|
(5,431
|
)
|
-
|
||||||||||||||||||||||
Unrealized gain on trading securities
|
3,783
|
-
|
3,783
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
Net income (loss) attributable to ACM Research, Inc.
|
$
|
6,567
|
$
|
(1,335
|
)
|
$
|
3,783
|
$
|
4,119
|
$
|
(81
|
)
|
$
|
(855
|
)
|
$
|
(5,431
|
)
|
$
|
6,205
|
||||||||||||
Basic EPS
|
$
|
0.34
|
$
|
0.22
|
$
|
(0.00
|
)
|
$
|
0.34
|
|||||||||||||||||||||||
Diluted EPS
|
$
|
0.30
|
$
|
0.19
|
$
|
(0.00
|
)
|
$
|
0.29
|
Six Months Ended June 30,
|
||||||||||||||||||||||||||||||||
2021
|
2020
|
|||||||||||||||||||||||||||||||
Actual
(GAAP)
|
SBC
|
Other non-operating adjustments
|
Adjusted
(Non-GAAP)
|
Actual
(GAAP)
|
SBC
|
Other non-operating adjustments
|
Adjusted
(Non-GAAP)
|
|||||||||||||||||||||||||
($ in thousands)
|
||||||||||||||||||||||||||||||||
Revenue
|
$
|
97,596
|
$
|
-
|
$
|
-
|
$
|
97,596
|
$
|
63,397
|
$
|
-
|
$
|
-
|
$
|
63,397
|
||||||||||||||||
Cost of revenue
|
(57,871
|
)
|
(181
|
)
|
-
|
(57,690
|
)
|
(33,813
|
)
|
(88
|
)
|
-
|
(33,725
|
)
|
||||||||||||||||||
Gross profit
|
39,725
|
(181
|
)
|
-
|
39,906
|
29,584
|
(88
|
)
|
-
|
29,672
|
||||||||||||||||||||||
Gross margin %
|
40.7
|
%
|
0.2
|
%
|
40.9
|
%
|
46.7
|
%
|
0.1
|
%
|
46.8
|
%
|
||||||||||||||||||||
Operating expenses:
|
||||||||||||||||||||||||||||||||
Sales and marketing
|
(11,097
|
)
|
(983
|
)
|
-
|
(10,114
|
)
|
(7,600
|
)
|
(258
|
)
|
-
|
(7,342
|
)
|
||||||||||||||||||
Research and development
|
(13,437
|
)
|
(508
|
)
|
-
|
(12,929
|
)
|
(8,898
|
)
|
(375
|
)
|
-
|
(8,523
|
)
|
||||||||||||||||||
General and administrative
|
(7,410
|
)
|
(873
|
)
|
-
|
(6,537
|
)
|
(4,532
|
)
|
(823
|
)
|
-
|
(3,709
|
)
|
||||||||||||||||||
Income from operations
|
$
|
7,781
|
$
|
(2,545
|
)
|
$
|
-
|
$
|
10,326
|
$
|
8,554
|
$
|
(1,544
|
)
|
$
|
-
|
$
|
10,098
|
||||||||||||||
Operating margin %
|
8.0
|
%
|
2.6
|
%
|
-
|
10.6
|
%
|
13.5
|
%
|
2.4
|
%
|
-
|
15.9
|
%
|
||||||||||||||||||
Change in fair value of financial liability
|
-
|
-
|
-
|
-
|
(5,431
|
)
|
-
|
(5,431
|
)
|
-
|
||||||||||||||||||||||
Unrealized gain on trading securities
|
2,736
|
-
|
2,736
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
Net income attributable to ACM Research, Inc.
|
$
|
12,037
|
$
|
(2,545
|
)
|
$
|
2,736
|
$
|
11,846
|
$
|
1,624
|
$
|
(1,544
|
)
|
$
|
(5,431
|
)
|
$
|
8,599
|
|||||||||||||
Basic EPS
|
$
|
0.63
|
$
|
0.62
|
$
|
0.09
|
$
|
0.48
|
||||||||||||||||||||||||
Diluted EPS
|
$
|
0.56
|
$
|
0.55
|
$
|
0.08
|
$
|
0.41
|